DeutschNewstral
Article
jdsupra.com on 2019-07-25 21:37
Labeling and Advertising Risks for CBD Companies - Cannabis Industry News Alert
Related news
- CBD and Cannabis Related Advertising – Trends and Takeawaysjdsupra.com
- Cannabis Advertisingjdsupra.com
- CBD Labeling and Marketing: The Straight Storyjdsupra.com
- The FDA Takes Aim at CBD Labelingjdsupra.com
- First Indicators of FDA’s Policy Decision on CBD and Cannabis-Derived Ingredients: “Only Limited Data” and “Real Risks”jdsupra.com
- CBD Industry Continues to Struggle With Product Content and Labelingjdsupra.com
- CBD Industry Beware: The False Labeling Class Action Has Arrivedjdsupra.com
- Proposition 65 Labeling Obligations Anticipated for CBD Products Containing THCjdsupra.com
- FDA’s Draft Guidance on Promotional Labeling and Advertising Considerationsjdsupra.com
- The TTB Modernizes Alcohol Labeling And Advertising Regulationsjdsupra.com
- Client Alert: Hemp/CBD Update- Federal and Florida Alertjdsupra.com
- CBD and False Advertising: Lessons Learned From The Food Courtjdsupra.com
- FTC Warns CBD Companies to Substantiate Their Advertisingjdsupra.com
- U.S. Cannabis Pioneers Face Chaotic Advertising Lawsjdsupra.com
- California’s proposed cannabis regulations seek to restrict ‘white labeling’jdsupra.com
- THC and California Proposition 65: What’s in Store for CBD Product Labeling?jdsupra.com
- Opportunities and risks for cannabis tenantsjdsupra.com
- CBD drugs moved to Schedule 5; no promises for cannabisjdsupra.com
- FDA Warns Cannabis Operator Curaleaf About CBD Marketing Claimsjdsupra.com
- Cannabis and CBD in 2020: 10 Key Takeaways From MJBizConjdsupra.com